Financial reports
10-Q
2002 Q2
Quarterly report
15 Mar 02
10-Q
2002 Q1
Quarterly report
17 Dec 01
10-K
2001 FY
Annual report
29 Oct 01
10-Q
2001 Q3
Quarterly report
19 Jun 01
NT 10-Q
Notice of late quarterly filing
15 Jun 01
10-Q
2001 Q2
Quarterly report
16 Mar 01
10-Q
2001 Q1
Quarterly report
14 Dec 00
10-K
2000 FY
Annual report
27 Oct 00
10-Q
2000 Q3
Quarterly report
14 Jun 00
10-Q
2000 Q2
Quarterly report
15 Mar 00
Current reports
8-K
Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016
25 May 10
8-K
Other events
27 Dec 01
8-K/A
Other events
18 Oct 01
8-K
Other events
24 Sep 01
8-K
Current report
27 Mar 01
8-K
Current report
30 May 00
8-K
Current report
22 May 00
8-K
Current report
1 Oct 99
8-K
Current report
24 Sep 99
8-K
Current report
28 Jul 99
Registration and prospectus
25-NSE
Exchange delisting
19 Jul 13
8-A12B/A
Registration of securities on exchange (amended)
3 Apr 13
424B3
Prospectus supplement
13 Dec 10
D
$400M in debt / Subsidiary Guarantees, sold $400M, 5 investors
6 Oct 10
424B3
Prospectus supplement
23 Apr 10
POSASR
Automatic shelf registration (post-effective amendment)
29 Mar 10
Proxies
DEF 14A
Definitive proxy
19 Feb 02
PREM14A
Preliminary proxy related to merger
23 Jan 02
DEF 14A
Definitive proxy
28 Nov 00
PRE 14A
Preliminary proxy
10 May 00
DEF 14A
Definitive proxy
15 Dec 99
PRE 14A
Preliminary proxy
3 Dec 99
DEF 14A
Definitive proxy
14 Dec 98
PRE 14A
Preliminary proxy
4 Dec 98
DEF 14A
Definitive proxy
26 Mar 98